Arbitrarily Herbal Treatments to Gain Weight as the Potential Cause of Pulmonary Embolism and Renal damage: A Case Report

Abdi, Masoomeh; Karamizadeh, Kiuomars

doi:10.22087/ijac.2022.383755.1002

Arbitrarily Herbal Treatments to Gain Weight as the Potential Cause of Pulmonary Embolism and Renal damage: A Case Report

Document Type : Case Report

Authors

Masoomeh Abdi ¹

Kiuomars Karamizadeh ²

¹ Aligoudarz School of Nursing, Lorestan University of Medical Science, Khorramabad, Iran.

² Aligoudarz Imam Jaafar Sadegh Hospital, Lorestan University of Medical Science, Khorramabad, Iran.

10.22087/ijac.2022.383755.1002

Abstract

Pulmonary embolism is caused by the formation of clots in the pulmonary arteries. This study is a case report to introduce a young woman who suffered a pulmonary embolism and kidney damage after consuming Fershteh fattening capsules. We report a 32-year-old woman who is referred to the emergency ward and suffers from weakness, lethargy, diarrhea, and vomiting. Due to the increase in renal and potassium markers, the patient is dialyzed urgently but suffers from shortness of breath, tachypnea, and tachycardia. A nuclear lung scan was performed after cardiac echocardiography and high pulmonary artery pressure, and pulmonary embolism was confirmed. After eight days, thrombosis was treated with intravenous heparin and discharged with oral warfarin. Arbitrary consumption of drugs without permission and without consulting a doctor can cause adverse effects on people.

Keywords

Pulmonary Embolism

Weight Gain

Renal Damage

Arbitrarily Treatment

1. Becattini C, Agnelli G, Lankeit M, Masotti L, Pruszczyk P, Casazza F, Vanni S, Nitti C, Kamphuisen P, Vedovati MC, De Natale MG. Acute pulmonary embolism: mortality prediction by the 2014 European Society of Cardiology risk stratification model. European Respiratory Journal. 2016 Aug 31;48(3):780-6.
2. Jiménez D, de Miguel-Díez J, Guijarro R, Trujillo-Santos J, Otero R, Barba R, Muriel A, Meyer G, Yusen RD, Monreal M, RIETE investigators. Trends in the management and outcomes of acute pulmonary embolism: analysis from the RIETE registry. Journal of the American College of Cardiology. 2016 Jan 19;67(2):162-70.
3. Fasanya A, Silvas K, Alhassan S, Patel K, Singh AC, Malik K. Venous thromboembolism and pulmonary embolism response teams: an overview. Critical Care Nursing Quarterly. 2017 Jul 1;40(3):237-50.
4. Mok KH, Wong SW, Wong YM, Foo D, Watson TJ, Ho HH. Clinical characteristics, risk factors and outcomes of South-East Asian patients with acute pulmonary embolism. International Journal of Cardiology. 2017 Dec 15;249:431-3.
5. Azarkish M, Abbaszadeh M, Namazi S, Reyhan SK. Herbal Treatments to Gain Weight as the Potential Cause of Portal Vein Thrombosis and Hepatic Damage: A Case Report. Case Reports in Clinical Practice. 2019;4(4):105-9.
6. https://news.fitshape.ir
7. Oray M, Abu Samra K, Ebrahimiadib N, Meese H, Foster CS. Long-term side effects of glucocorticoids. Expert opinion on drug safety. 2016 Apr 2;15(4):457-65.
8. Harrison ME, Norris ML, Robinson A, Spettigue W, Morrissey M, Isserlin L. Use of cyproheptadine to stimulate appetite and body weight gain: A systematic review. Appetite. 2019 Jun 1;137:62-72.
9. Kim SY, Yun JM, Lee JW, Cho YG, Cho KH, Park YG, Cho B. Efficacy and tolerability of cyproheptadine in poor appetite: a multicenter, randomized, double-blind, placebo-controlled study. Clinical Therapeutics. 2021 Oct 1;43(10):1757-72.
10. Mohammadi MR, Mostafavi SA, Hosseinzadeh P, Nojoumi M, Asadian-Koohestani F. Comparing the Effects of Folic Acid and Cyproheptadine on Appetite, Weight, and ADHD Symptoms in Children with ADHD: A Randomized Clinical Trial. Journal of Iranian Medical Council. 2021.
11. Merhar SL, Pentiuk SP, Mukkada VA, Meinzen‐Derr J, Kaul A, Butler DR. A retrospective review of cyproheptadine for feeding intolerance in children less than three years of age: effects and side effects. Acta Paediatrica. 2016 Aug;105(8):967-70